Dow Up 0.26% Nasdaq Down 1.07%

AbbVie Inc. (ABBV)

-NYSE
57.93 Up 0.05(0.09%) Sep 15, 4:00PM EDT
|After Hours : 58.13 Up 0.20 (0.35%) Sep 15, 5:18PM EDT
Prev Close:57.88
Open:57.75
Bid:56.64 x 100
Ask:58.68 x 100
1y Target Est:67.38
Beta:1.928
Earnings Date:Oct 23 - Oct 27 (Est.)
Day's Range:57.47 - 58.15
52wk Range:44.02 - 58.77
Volume:8,632,657
Avg Vol (3m):11,202,800
Market Cap:92.21B
P/E (ttm):22.54
EPS (ttm):2.57
Div & Yield:1.68 (3.20%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ABBV

Comparison

Symbol% ChgMkt Cap
ABBVUp 0.09%92.21B
MRKDown 0.05%171.69B
NVSUp 0.45%228.50B
PFEUp 1.66%189.72B

Key Statistics

Forward P/E (1 yr):14.82
P/S (ttm):4.78
Ex-Dividend Date:11-Jul-14

Analysts

Annual EPS Est (Dec-14) :3.16
Quarterly EPS Est (Sep-14) :0.77
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):1.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune d... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback